- Release Date: 05/08/21 09:52
- Summary: Veyonda Survival Advantage in LuPSMA Therapy Confirmed
- Price Sensitive: Yes
- Download Document 382.78KB
- Forums
- ASX - By Stock
- Ann: Veyonda Survival Advantage in LuPSMA Therapy Confirmed
NOX
noxopharm limited
Add to My Watchlist
0.00%
!
4.8¢

Ann: Veyonda Survival Advantage in LuPSMA Therapy Confirmed
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.02M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 189676 | 4.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.8¢ | 163352 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 189676 | 0.045 |
1 | 370000 | 0.044 |
1 | 38819 | 0.043 |
3 | 588000 | 0.042 |
1 | 24390 | 0.041 |
Price($) | Vol. | No. |
---|---|---|
0.048 | 163352 | 1 |
0.056 | 46264 | 1 |
0.057 | 10730 | 1 |
0.061 | 16393 | 1 |
0.070 | 523 | 1 |
Last trade - 10.22am 15/07/2025 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |
Day chart unavailable
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
SPONSORED BY The Market Online